| Literature DB >> 24250555 |
Zahra Kiasalari1, Mohsen Khalili, Mehrdad Roghani, Azam Sadeghian.
Abstract
Considering the high rate of epilepsy today, with respect to the insufficiency of the available therapies, new strategies and methods are recommended for medical treatment of epileptic patients. Therefore, the present study experimentally investigated the anticonvulsant effect of a herbal medicine candidate brassica nigra, by using kindling method. Sixty male mice were randomly selected and divided into six experimental groups (n = 10) including: 1-control, 2-pentylentetrazole (PTZ)-kindled mice, 3-positive control group received valproate (100 mg/Kg) as anti-convulsant drug, 4-5 and 6 received brassica nigra seed extract in three doses (75, 150 and 300 mg/Kg; IP). All groups except for the control ones were kindled by 11 period injections of PTZ (35 mg/Kg; IP). In the 12th injection, all groups except for the control group were tested for PTZ challenge dose (75 mg/Kg). However, the exhibited phases of seizure (0-6) were observed and noted till 30 min after the PTZ injection. At last, the brains of all the mice were removed and then malondialdehyde (MDA), superoxide dismutase (SOD) and nitric oxide (NO) levels of the brain tissues were determined. Statistical analysis of the data shows that the seed extract could reduce the intensity, improvement and duration of seizure. In addition, the brassica nigra extract increased the SOD and NO levels and decreased the MDA level in the brain tissues. Attained results show that the extract of Brassica nigra seed can be used in grand mal seizure treatment. Moreover, the antiepileptic effect of this extract is probably caused by its antioxidant properties and acts via enzyme activity mechanism.Entities:
Keywords: Brassica nigra; Epilepsy; MDA; NO; PTZ; SOD
Year: 2012 PMID: 24250555 PMCID: PMC3813178
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Figure 1Effect of Brassica nigra pretreatment on the PTZ-induced kindling intensity. BN shows Brassica nigra. *p < 0.05 and **p < 0.01 indicate significant differences as compared to PTZ-kindled group.
Figure 2Effect of valproate (100 mg/Kg) and three doses of brassica nigra (75, 150 and 300 mg/Kg) on the latency of arriving to phase 5 of seizure. n = 10 in each group. VA and BN indicate valproate and brassica nigra respectively
Figure 3Effect of valproate (100 mg/Kg) and three doses of brassica nigra (75, 150 and 300 mg/K) on the remaining time in the phase 5. n = 10 in each group. VA and BN indicate valproate and brassica nigra respectively. *: p < 0.05 shows significant difference as compared to PTZ-kindled group
The effect of valproate and three doses of brassica nigra on the NO, MDA and SOD levels of brain tissue on the PTZ-kindled mice
|
|
|
|
|
|---|---|---|---|
|
| |||
| Control | 0.03 0.53 ± | 1.89 17.69 ± | 0.13 ± 00 |
| PTZ | 0.6 ± 0.03 | 25.63 ± 2.11 | 0.1 ± 0.01 |
| PTZ + valproate | 0.4 ± 0.04 | 20.46 ± 1.98 | 0.13 ± 0.03 |
| PTZ + BN (75 mg/Kg) | 0.66 ± 0.07 | 23.61 ± 1.23 | 0.12 ± 00 |
| PTZ + BN (150 mg/Kg) | 0.74 ± 0.03 | 26.21 ± 1.64 | 0.16 ± 0.01 |
| PTZ + BN (300 mg/Kg) | 0.81 ± 0.06 | 18.29 ± 1.18 | 0.14 ± 0.02 |
Brain levels of NO, MDA and SOD are compared in six groups. In each group, n = 10 and BN indicates brassica nigra. * and # show significant differences as compared to control and PTZ-kindled groups respectively (p < 0.05)